Mar 06, 2019
US Food and Drug Administration Chief Scott Gottlieb decided to tender his resignation which took everyone by surprise. His departure is a potential blow to the health care industry. Dr.Scott Gottleib – a physician, a medical policy expert, and public health advocate was sworn in as the 23rd Commissioner of FDA. ...
Read More...
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper